Neuroblastoma cells express the polysialylated form of the neural cell
adhesion molecule (NCAM), which normally becomes restricted to a few
neural tissues after embryogenesis. In this study, we investigated ser
um levels of polysialylated NCAM in 14 children with different grades
and stages of neuroblastoma using an immunoluminescence assay, and com
pared the results to 269 healthy control subjects. Simultaneously the
polysialylated NCAM content of the tumours was determined by immunohis
tochemistry. Serum levels were dramatically elevated (more than sixfol
d) in children with advanced stages and fatal courses of disease, wher
eas children with differentiated tumour types and limited disease had
low or normal levels. Serum concentrations correlated with the polysia
lylated NCAM content of the tumours, and they decreased during success
ful therapy. We therefore suggest polysialylated NCAM to be a useful m
arker monitoring childhood neuroblastoma.